Date of announcement  2016/02/22 
Time of announcement  21:51:46 
Date of events  2016/02/22  
To which item it meets paragraph 24 
Statement  1.Name and nature of the subject matter (if preferred shares,the terms and
  conditions of issuance shall also be indicated,e.g.dividend yield):
interest in The Best APF Limited (“The Best”).
2.Date of occurrence of the event:2016/02/22
3.Volume, unit price, and total monetary amount of the transaction:
(1)Volume and unit price: per terms of capital injection
(2)Total monetary amount of the transaction: Up to
USD 5,000,000.
4.Counterpart to the trade and its relationship to the Company(if the
  trading counterpart is a natural person and furthermore is not an actual
  related party of the Company, the name of the trading counterpart is not
  required to be disclosed):
(1) Counterpart to the trade: The Best
(2) Relationship to the Company: None.
5.Where the counterpart to the trade is an actual related party,a public
  announcement shall also be made of the reason for choosing the related
  party as trading counterpart and the identity of the previous owner
  (including its relationship with the company and the trading counterpart),
  price of transfer, and date of acquisition:
Not applicable.
6.Where a person who owned the property within the past five years has been
  an actual related person of the company, a public announcement shall also
  include the dates and prices of acquisition and disposal by the related
  person and the person’s relationship to the company at those times:
 Not applicable.
7.Matters related to the creditor's rights currently being disposed of
  (including types of collateral of the disposed creditor's rights;if the
  creditor's rights are creditor's rights toward a related  person, the name
  of the related person and the book amount of the creditor's rights toward
  such related person currently being disposed of must also be announced):
 Not applicable.
8.Anticipated profit or loss from the disposal (not applicable in cases of
  acquisition of securities) (where originally deferred, the status or
  recognition shall be stated and explained): Not applicable.
9.Terms of delivery or payment (including payment period and monetary
  amount), restrictive covenants in the contract, and other important
  stipulations:Follow the capital call of The Best.
10.The manner in which the current transaction was decided, the reference
   basis for the decision on price, and the decision-making department:
(1) The manner in which the current transaction was
decided, the reference basis for the decision on
price: per terms of this capital investment
(2) The decision-making department: Board of
directors of CI I.
11.Net worth per share of company underlying securities acquired or disposed
   of:Not applicable.
12.The discrepancy between the reference price of private placement and the
   transaction amount per share is 20 percent or more of the transaction
   amount: Not applicable.
13.Current cumulative volume, amount, and shareholding percentage of
   holdings of the security being traded (including the current trade) and
   status of any restriction of rights (e.g.pledges):
(1) Current cumulative volume: Not applicable.
(2) Amount: Up to USD 5,000,000.
(3) Shareholding percentage of holdings of the security
being traded:  per terms of this capital injection
(4) Status of any restriction of rights: None
14.Current ratio of private placement of securities (including the current
   trade) to the total assets and shareholder's equity as shown in the most
   recent financial statement and the operating capital as shown in the most
   recent financial statement:
(1) Current ratio of private placement of securities
(including the current trade) to the total
assets: 59.05%.
(2) Current ratio of private placement of securities
(including the current trade) to the shareholder's
equity: 59.05%.
(3) The operating capital: USD 101,996,082
15.Broker and broker's fee:None.
16.Concrete purpose or use of the acquisition or disposition:
For the need of portfolio diversification.
17.Do the directors have any objection to the present transaction?:
No.
18.The trading counterparty is a related party:No.
19.Approval date by board of directors:
 Not applicable.
20.Recognition date by supervisors or submission date by audti committee:
 Not applicable.
21.Has the CPA issued an opinion on the unreasonableness of the price of
   the current transaction?: Not applicable.
22.Any other matters that need to be specified:
1. CI I's investment cost is up to US$5,000,000 together
with deal related expenses on the pro rata basis but
limited to US$100,000. There will be an updated
announcement when CI I successfully patriciates in
this capital injection and all investment details are
finalized.
2. Reference is made to and applied the exchange
rate as of February, 18 2016, which was USD 1 against
NTD 33.363 in this announcement.